Fake News! Army Dismisses Report Of Operation Positive Identification Exercise

The Nigerian Army has regarded as ‘Fake Alert’ a viral post of planned nationwide ‘Operation Positive Identification’ (OPI) exercise credited to the Armed Forces.

In a social media post, the Army informed the public that the security advisory which is supposed to commence from November 1, 2019, to December 23, 2019, should be disregarded.

The advisory which was doctored with the Army logo was quoted as “Planned Nationwide Military Operation by the Nigerian Armed Forces.

“It has been officially declared that effective from 1st November 2019 to 23rd December 2019, residents shall witness large numbers of uniformed Nigerian Army Personnel parading the roads in an exercise known as OPI”

It added that residents should move around with valid means of identification, and obey all directives by security agents.

This news has however triggered a reaction from members of House of Representatives who have urged President Muhammadu Buhari to call off the planned operation positive identification exercise of the military.

In a motion raised by the House minority leader, Ndudi Elumelu as a matter of urgent public importance, the lawmaker expressed worry that the exercise will instill fear in the heart of Nigerians.

The motion also maintained that the operation will strip Nigerians of their constitutionally guaranteed freedom of movement and instill fear, anxiety, and panic in the entire polity, adding that the nationwide operation would amount to an indirect imposition of a state of emergency across the country by the Army.

In their contributions, some lawmakers opined that it is the responsibility of the police and not the army.
The house committee on army is to meet with the chief of army staff for a clearer understanding of the motive of the operation.

See photo below of the controversial news:

 

About Admin

Check Also

Elon Musk’s brain chip to help blind people see gets approval

Elon Musk’s brain-chip startup, Neuralink, has received the US Food and Drug Administration’s “breakthrough device” …

Leave a Reply